BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34929443)

  • 1. Generation of three human induced pluripotent stem cell lines with IRX5 knockout and knockin genetic editions using CRISPR-Cas9 system.
    Canac R; Caillaud A; Cimarosti B; Girardeau A; Hamamy H; Reversade B; Bonnard C; Al Sayed ZR; David L; Poschmann J; Lemarchand P; Lamirault G; Gaborit N
    Stem Cell Res; 2022 Jan; 58():102627. PubMed ID: 34929443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human model of IRX5 mutations reveals key role for this transcription factor in ventricular conduction.
    Al Sayed ZR; Canac R; Cimarosti B; Bonnard C; Gourraud JB; Hamamy H; Kayserili H; Girardeau A; Jouni M; Jacob N; Gaignerie A; Chariau C; David L; Forest V; Marionneau C; Charpentier F; Loussouarn G; Lamirault G; Reversade B; Zibara K; Lemarchand P; Gaborit N
    Cardiovasc Res; 2021 Jul; 117(9):2092-2107. PubMed ID: 32898233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient.
    Costantini DL; Arruda EP; Agarwal P; Kim KH; Zhu Y; Zhu W; Lebel M; Cheng CW; Park CY; Pierce SA; Guerchicoff A; Pollevick GD; Chan TY; Kabir MG; Cheng SH; Husain M; Antzelevitch C; Srivastava D; Gross GJ; Hui CC; Backx PH; Bruneau BG
    Cell; 2005 Oct; 123(2):347-58. PubMed ID: 16239150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of two homozygous SHOX2 knock-out human induced pluripotent stem cell lines using CRISPR/Cas9.
    Rädecke K; Gore A; Burau K; Laugsch M; Köhler K; Rappold GA; Hoffmann S
    Stem Cell Res; 2023 Jun; 69():103089. PubMed ID: 37028180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of homozygous and heterozygous REEP1 knockout induced pluripotent stem cell lines by CRISPR/Cas9 gene editing.
    Korneck M; Leonhardt A; Schöls L; Hauser S
    Stem Cell Res; 2024 Jun; 77():103378. PubMed ID: 38479332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a heterozygous SCN5A knockout human induced pluripotent stem cell line by CRISPR/Cas9 edition.
    Gizon M; Duboscq-Bidot L; El Kassar L; Bobin P; Ader F; Giraud-Triboult K; Charron P; Villard E; Fontaine V; Neyroud N
    Stem Cell Res; 2022 Apr; 60():102680. PubMed ID: 35093717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of heterozygous (MCRIi030-A-1) and homozygous (MCRIi030-A-2) NR2F2/COUP-TFII knockout human iPSC lines.
    Ferreira LGA; Cabral-da-Silva MC; Pachernegg S; van den Bergen JA; Robevska G; Vlahos K; Howden SE; Ng ES; Dias-da-Silva MR; Sinclair AH; Ayers KL
    Stem Cell Res; 2024 Apr; 76():103374. PubMed ID: 38458031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of heterozygous (MRli003-A-3) and homozygous (MRli003-A-4) TRPM4 knockout human iPSC lines.
    Zhang F; Meier AB; Lipp P; Laugwitz KL; Dorn T; Moretti A
    Stem Cell Res; 2022 Apr; 60():102731. PubMed ID: 35245852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of heterozygous (MRli003-A-5) and homozygous (MRli003-A-6) voltage-sensing knock-in human iPSC lines by CRISPR/Cas9 editing of the AAVS1 locus.
    Zhang F; Meier AB; Sinnecker D; Engelhardt S; Lipp P; Laugwitz KL; Dorn T; Moretti A
    Stem Cell Res; 2022 May; 61():102785. PubMed ID: 35421847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of two NAGLU-mutated homozygous cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 to model Sanfilippo B syndrome.
    Benetó N; Cozar M; Gort L; Pacheco L; Vilageliu L; Grinberg D; Canals I
    Stem Cell Res; 2020 Jan; 42():101668. PubMed ID: 31825816
    [No Abstract]   [Full Text] [Related]  

  • 12. Generation of induced pluripotent stem cell line (TMOi001-A-11) carrying a homozygous deletion in the synemin gene using CRISPR/Cas9.
    Gargano C; Vartanian-Grimaldi JS; Hovhannisyan Y; Joanne P; Agbulut O; Li Z; Parlakian A; Decaux JF
    Stem Cell Res; 2023 Dec; 73():103254. PubMed ID: 38035530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a homozygous RANGRF knockout hiPSC line by CRISPR/Cas9 system.
    Jiang M; Tang C; Luo X; Zhou X; Chen M; Chi Y; Lai L; Zou Q
    Stem Cell Res; 2023 Sep; 71():103136. PubMed ID: 37327621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative and antagonistic roles for Irx3 and Irx5 in cardiac morphogenesis and postnatal physiology.
    Gaborit N; Sakuma R; Wylie JN; Kim KH; Zhang SS; Hui CC; Bruneau BG
    Development; 2012 Nov; 139(21):4007-19. PubMed ID: 22992950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a homozygous ZBTB7A knockout human induced pluripotent stem line by CRISPR/Cas9 editing.
    Chen D; Song B; Cheng Y; Zhu L; Lu D; Liu N; Yang Y; Sun X
    Stem Cell Res; 2021 Aug; 55():102494. PubMed ID: 34403853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Seo HH; Han HW; Kim JH
    Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a homozygous ABCA7-knockout human iPSC line using the CRISPR/Cas9 system.
    Guan M; Chai Y; Yi R; Chen Y; Ip JPK; Ye T; Chen Y
    Stem Cell Res; 2023 Feb; 66():103000. PubMed ID: 36521383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of homozygous Na
    Maurer W; Hartmann N; Argyriou L; Sossalla S; Streckfuss-Bömeke K
    Stem Cell Res; 2022 Apr; 60():102677. PubMed ID: 35092938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9.
    Chen S; Luo Z; Ward C; Ibañez DP; Liu H; Zhong X; Sharma NK; Qin B; Fan W; Wang D
    Stem Cell Res; 2020 May; 45():101804. PubMed ID: 32339904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a homozygous ARHGAP11B knockout hiPSC line by CRISPR/Cas9 system.
    Liu Y; Jin Y; Chen T; Wu Y; Peng X; Li W; Wei S; Chen M; Zou Q; Guo S; Xu J; Tang C; Zhou X
    Stem Cell Res; 2022 May; 61():102764. PubMed ID: 35358830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.